DitropanXL: FDA Approved Drug to Treat Urinary Incontinence

Each year, millions of individuals will suffer from symptoms associated with urinary incontinence. Of these, many adults will seek out medical treatment and, unfortunately, be diagnosed with a condition known as overactive bladder. In an effort to provide appropriate urinary tract improvement, a healthcare professional, usually a urologist will develop a tailored treatment plan in an effort to control bladder spasms and urine output. As part of this treatment program, the use of a tablet once per day, known as DitropanXL, may be prescribed. Understanding the use, dosing and side effects of DitropanXL, will equip the urinary incontinence sufferer with a better understanding in the overall treatment plan initiated as part of a proactive approach to reducing the risk of further urinary tract complications.

DitropanXL is used in the treatment of an overactive bladder but may also be used to treat patients at risk for other urinary incontinence conditions and disorders. DitropanXL lends its success in slowing the involuntary bladder muscle contractions which lead to involuntary urinary incontinence. Dosing of DitropanXL will vary depending on the health status patient after ruling out other urinary incontinence complications. As a tablet taken once per day, DitropanXL is a convenient approach to preventing to improving overactive bladder and, therefore, improving the quality of daily living for the sufferer. Dosing levels will vary from five milligrams to 15 milligrams per tablet with some overactive bladder sufferers requiring doses as high as 30 milligrams. While the effects of DitropanXL are not realized immediately, most patients will benefit from the use of DitropanXL as early as two weeks from initiating treatment.